ArticlePDF Available

Back pain in chronic renal failure

Authors:
  • Pushpawati Singhania Research Institute, New Delhi India

Figures

Content may be subject to copyright.
Images in Nephrology
(Section Editor: G. H. Neild)
Back pain in chronic renal failure
Ravi Bansal and Suresh C. Tiwari
Department of Nephrology, All India Institute of Medical Sciences, New Delhi 110029, India
Keywords: back pain; chronic renal failure; fluorosis
Back pain in chronic renal failure
Patient SK, a 40-yr-old female, resident of Bhagalpur
village in Bihar, India, was operated for gallstones
3 years previously. On pre-operative checkup, mild
renal dysfunction was detected. She was asymptomatic
for renal disease with serum creatinine of 159 mmol/l
(1.8 mg/dl), bland urinary sediment and small echo-
genic kidneys on ultrasound. She was put
on conservative management for chronic renal failure
(CRF) and was doing well till 1 year ago. Since then
she developed back pain, which increased on walking.
Pain was dull in character without any radiation. There
were no systemic complaints. In the past month when
her pain increased substantially, causing discomfort in
day-to-day activities. On investigation she was found
to have moderate renal failure with blood urea
nitrogen (BUN) of 11.8 mmol/l and serum creatinine
of 309 mmol/l (3.5 mg/dl). Other labs showed serum
calcium of 2.4 mmol/l, phosphorus 1.1 mmol/l, alkaline
phosphatase 243 U/l, uric acid 381 mmol/l and intact
parathyroid hormone (iPTH) of 182.0 pg/ml. X-rays
of bilateral forearms, pelvis and spine were taken
(Figures 1–3, respectively), which revealed generalized
increase in bone density, degenerative changes
with osteophytes in lumber vertebra, calcification of
bilateral iliolumbar and sacrospinous ligaments and
interosseous membrane calcification in forearms.
Definitive diagnosis was reached with estimation of
fluoride levels in blood and urine, which were
0.291 mg/l and 0.962 mg/l (15.3 and 50.6 mmol/l),
respectively. Her drinking water source, ground water
from a tubewell, was found to contain 3.910 mg/l
(205.9 mmol/l) of fluoride. She was diagnosed to have
fluorosis with moderate CRF and was advised to use
domestic reverse-osmosis-treated water for cooking
and drinking.
Main sources of fluoride include food and water.
About 50–70% of fluoride is excreted by the kidneys
[1]. Individuals with kidney disease have decreased
ability to excrete fluoride in urine and are at risk of
developing fluorosis even at normal recommended
limit of 0.7 to 1.2 mg/l (37–63 mmol/l) of fluoride in
drinking water [2]. In fluorosis with normal renal
function, urine fluoride rises above 0.5–4.48 mg/l
(26–236 mmol/l) and may reach 1.5–13.0 mg/l
(79–685 mmol/l) [3]. Serum fluoride rises to
0.04–0.28 mg/l (2.1–14.7 mmol/l) in such patients [1].
Fluoride is bone-seeking due to its high affinity for
calcium phosphate and therefore accumulates in bone.
Radiological changes can be quite similar to changes
of renal osteodystrophy, and therefore the diagnosis
may be missed unless specifically investigated.
Conflict of interest statement. None declared.
Correspondence and offprint requests to: Dr Ravi Bansal, Senior
Research Associate, Department of Nephrology, AIIMS,
New Delhi 110029, India. Email: dr_ravibansal@yahoo.com
Fig. 1. Plain film of both forearms showing interosseous membrane
calcification.
Nephrol Dial Transplant (2006) 21: 2331–2332
doi:10.1093/ndt/gfl254
Advance Access publication 23 May 2006
ßThe Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
For Permissions, please email: journals.permissions@oxfordjournals.org
by guest on April 28, 2012http://ndt.oxfordjournals.org/Downloaded from
References
1. Reddy DR, Deme SR, Fluorosis . In: Chopra JS, Sawhney IMS
eds. Neurology in Tropics, B.I. Churchill Livingstone, New Delhi,
India: 1999; 82–92
2. Arnala I, Alhava EM, Kauranen P. Effects of fluoride on bone in
Finland. Histomorphometry of cadaver bone from low and high
fluoride areas. Acta Orthop Scand 1985; 56: 161–166
3. Sesikaran B, Rao SM, Krishnamurti D, Reddy DR. Studies in
sural nerve biopsies in endemic skeletal fluorosis. Fluride 1994; 27:
189–193
Received for publication: 6.3.06
Accepted in revised form: 10.4.06
Fig. 2. Plain film of pelvis showing calcification of bilateral
iliolumbar (black arrow) and sacrospinous ligaments (white arrow).
Fig. 3. Plain film lateral view of lumbar spine showing increase
in bone density with osteophytes.
2332 R. Bansal and S. C. Tiwari
by guest on April 28, 2012http://ndt.oxfordjournals.org/Downloaded from
... The The effects of fluoride on bone are dose dependent. Individuals with kidney disease have decreased ability to excrete fluoride in urine and are at high risk of developing fluorosis even at the recommended limit of (0.7 to 1.2 mg/l) fluoride for the general public (Bansal and Tiwari, 2006). A naturally occurring high level of fluoride in drinking water (> 1.5 ppm) ...
Thesis
Full-text available
Chronic kidney disease of uncertain etiology (CKDu) is a primary tubulointerstitial disease manifest with minimal or absent albuminuria in the early stages. The literature review suggests multiple environmental factors pose a risk in causing CKDu in addition to traditional elements. Serum creatinine and albuminuria have been used for many decades to measure glomerular function and damage, respectively. However, the diagnosis and management of CKDu mostly rely on serum creatinine, which is a delayed marker that indicates disease after substantial renal damage. Molecular biomarkers are potential candidates to improve the outcomes of kidney diseases. Furthermore, cytokine biomarkers can be used to explore the pathogenesis and to differentiate phenotypes of kidney diseases. This thesis clinically validated biomarkers for early detection of CKDu and complications arising from renal failure. We evaluated serum creatinine, serum cystatin C and albumin creatinine ratio (ACR) over dipstick proteinuria for CKDu screening. In addition, we described the clinicopathological profiles of the chronic interstitial nephritis (CIN), acute interstitial nephritis (AIN), and subclinical phenotypes of CKDu before evaluating biomarkers. Candidate renal biomarkers (n=27) were measured on 78 stage 1-4 CKDu (early stages) patients to evaluate biomarker manifestation in the disease state and to interpret the pathophysiology. Selected eight urinary biomarkers from 27 candidates were measured in cases and four different controls to identify the best marker panel to differentiate CKDu from other chronic kidney diseases. Serum transforming growth factor-beta-1 (TGF-β1) and creatinine were measured in CKDu patients with different phenotypes and healthy controls to differentiate phenotypes. Also, a clinical trial was conducted to evaluate the effectiveness of prednisolone and doxycycline on AIN presentation. Only biopsy proven CKDu cases were used in the biomarker validation process. All biomarkers were quantified by the Luminex assay except ACR and serum creatinine. Serum creatinine and ACR were recommended for population screening purposes in Sri Lanka based on accessibility to the tests in the endemic regions. Upregulation of neutrophil gelatinase-associated lipocalin (NGAL), retinol-binding protein-4 (RBP-4), β2-microglobulin (β2-MG), Cystatin C, and α1-microglobulin (α1-MG) and fatty acid-binding protein-1 (FABP-1), TGF-β1 and Collagen-IV in early stages of CKDu suggest active ongoing renal fibrosis and tubular damage. Whereas downregulated interleukins IL-6, IL-10, and pentraxin (PTX-3) indicate a low-grade inflammation. Moreover, serum osteoprotegerin (OPG), parathyroid hormone (PTH), Renin, and fibroblast growth factor 23 (FGF-23) were also downregulated, suggesting a low prevalence of mineral bone disease and cardiovascular events in early CKDu. Osteopontin (OPN), kidney injury molecule-1 (KIM1), and RBP4 combination distinguishes CKDu from known causes of CKD with both sensitivity and specificity ≥0.93. Urinary α1-MG is the best candidate to detect Subclinical cases when creatinine is normal. Serum TGF β1 is a potential biomarker to differentiate AIN from CIN phenotypes. Steroid therapy for AIN presentation may delay the progression of CKDu. In conclusion, this thesis identified potential biomarkers for the early detection of CKDu and its’ renal complications. However, none of the biomarkers are pathognomonic for CKDu, and need to be interpreted with clinical justification. Further case-control and cohort studies are warranted before clinical use of these biomarkers.
... Patients with reduced glomerular filtration rates have a decreased ability to excrete fluoride in the urine. These patients may develop skeletal fluorosis even at 1 ppm fluoride in the drinking water [17]. . Whether or not the body burden of fluoride may further damage the diseased kidneys is unknown. ...
... Skeletal fluorosis may be affected by multiple factors for eight risk for developing skeletal fluorosis, and the course the disease will take, can be strongly influenced by the presence or absence of predisposing factors, which include impaired kidney function; dietary deficiencies; genetic predisposition; gastric acidity; physical/repetitive stress; age; and pregnancy/lactation. Individuals with kidney disease have decreased ability to excrete fluoride in urine and are at risk of developing fluorosis even at normal recommended limit of 0.7 to 1.2 mg/l [11,12] . Previous studies in mice and humans, as well as epidemiological studies, have demonstrated that severity of dental fluorosis cannot be explained simply by the amount of fluoride in the tooth structure, indicating that genetics (susceptiblity to fluoride) plays an important role in dental fluorosis severity. ...
Article
Full-text available
Fluoride affects bone strength, by replacing hydroxyl ions in bone crystals to form fluoroapatite, and increasing both the osteoblast and osteoclast activity. Daily intake of naturally fluoridated water, is inevitable in many areas and countries throughout the world, it remains a major health issue as it has been suggested that fluorides may paradoxically aggravate osteoporosis and increase osteoporotic fractures and several epidemiological studies have been published showing that there is an increased rate of bone fractures i.e mostly hip fractures in older people in living in fluoridated areas. This study was carried out to ascertain the fact that high fluoride intake and low calcium may have on bone deformities in patients.
... Children are the most susceptible, and accumulate fluoride at a greatly accelerated rate compared with adults (Teotia et al. 1998). Patients with kidney disorders are also at high risk for skeletal fluorosis, given that kidneys are essential for filtering fluoride (Gerster et al. 1983;Krishnamachari 1986;Bansal and Tiwari 2006). ...
Article
Full-text available
Fluoride is ubiquitously present throughout the world. It is released from minerals, magmatic gas, and industrial processing, and travels in the atmosphere and water. Exposure to low concentrations of fluoride increases overall oral health. Consequently, many countries add fluoride to their public water supply at 0.7–1.5 ppm. Exposure to high concentrations of fluoride, such as in a laboratory setting often exceeding 100 ppm, results in a wide array of toxicity phenotypes. This includes oxidative stress, organelle damage, and apoptosis in single cells, and skeletal and soft tissue damage in multicellular organisms. The mechanism of fluoride toxicity can be broadly attributed to four mechanisms: inhibition of proteins, organelle disruption, altered pH, and electrolyte imbalance. Recently, there has been renewed concern in the public sector as to whether fluoride is safe at the current exposure levels. In this review, we will focus on the impact of fluoride at the chemical, cellular, and multisystem level, as well as how organisms defend against fluoride. We also address public concerns about fluoride toxicity, including whether fluoride has a significant effect on neurodegeneration, diabetes, and the endocrine system.
... [42] People with impaired kidney function are unable to excrete efficiently and retain Fluoride, even at normal recommended limit. [43] It has been known that people with renal failure are at high risk of developing skeletal fluorosis. In such people elevated plasma Fluoride levels and accumulation of Fluoride in the skeleton is increased. ...
... Kidney malfunction can impede this excretion, thereby causing an increased deposition of Finto bones and eventually causes skeletal fluorosis. Individuals with kidney disease have decreased ability to excrete Fin urine and are at risk of developing fluorosis even at normal recommended limit of 0.7 to 1.2 mg/l (Banzal and Tiwari, 2006). Persons with renal failure can have a four-fold of spontaneous bone fractures and akin to skeletal fluorosis even at 1.0 mgF -/l in drinking water (Ayoub and Gupta, 2006). ...
... They have elevated plasma F levels compared with normal healthy persons and are at high risk of fluorosis even at normal recommended limits of F in drinking water. 3,4 F exposure through drinking water induces alteration in kidney function of animals including man. 5,6 N-acetyl-β-D-glucosaminidase (NAG) and αglutathione-S-transferase (α-GST) are markers of renal tubular damage. ...
Article
Protective effects of melatonin (MLT) (10 mg/kg bw/day) against kidney in adult female albino mice induced by fluoride (F) (10 mg NaF/kg bw/day) are reported. Biochemical indices studied were levels of total protein, creatinine, lipid peroxidation (LPO), glutathione (GSH), and activities of enzymes including acid phosphatase (ACP), alkaline phosphatase (ALP), and succinate dehydrogenase (SDH). NaF treatment resulted in a significant decline in the activities of ACP, ALP, and SDH as well as the levels of protein and creatinine along with a reduction in kidney gravimetric data. The levels of the lipid peroxides were enhanced,accompanied by a marked decrease in GSH. These changes appear to be due to kidney damage caused by F. Pretreatment with melatonin ameliorated these marked changes, thereby confirming antioxidant effects of melatonin.
... renal osteodystrophy (Ludlow et al., 2007). Individuals with renal disease are at risk of developing fluorosis even at the normal recommended limit of 0.7 to 1.2 mg/L (Bansal and Tiwari, 2006). Persons with renal failure can have a fourfold increase in skeletal fluoride content, are at more risk of spontaneous bone fractures even at 1.0 μg/L fluoride in drinking water (Ayoob and Gupta, 2006). ...
Article
In this study the F- ion concentration levels of 209 well water samples belonging to previous construction analysis (CA) and a total of 121 well water samples belonging to the current study (CS) in Al-Butana region of Central Sudan were investigated and located (mapped) using the geographical information system (GIS). The GIS- map indicates that the majority of F- levels ranging between 0.5 and 1.5 mg/l dominates the northern part of the study area and the levels below 0.5 mg/l dominates the southern part of the study area whereas the levels above 1.5 mg/l are limited and are scattered, randomly, throughout the study area. The results obtained revealed considerable spatial variations in the occurrence of fluoride even within the same community area, F- levels ranging between 0.0 and 6 mg/l were found in boreholes drilled in Rufaa' Town. The majority of the investigated boreholes viz., 39.71% and 42.98% were found having F- levels below 0.5 mg/l whereas only 0.96% and 3.3% were found beyond the level of 2.5 mg/l, for the CA and CS, respectively. The wide range of F- levels (from 0 to 7 mg/l in the CA and from 0 to 2.6 mg/l in the CS) revealed the variability in the spatial distribution of F- in the study area. 94.26% and 88.43% of the groundwater samples were found below the maximum recommended level of 1.5 mg/l set for F- in drinking water by each of SSMO (2002) whereas only 5.75% and 11.58% were found in excess of this level, for the CA and CS, respectively. The decrease in the mean value of F- in the investigated boreholes from 1.4 mg/l in the CA analysis to 0.6 mg/l in the CS analysis, indicates that F- levels in the investigated boreholes has the tendency to decrease during pumping. Mottled teeth are widely observed among residents in the study area in spite of fluoride compliancy to SSMO standards. Therefore, dental fluorosis, in the study area, is not unlikely to occur.
Article
Full-text available
No Abstract Available.
Article
Full-text available
In three different areas of Finland, fluoride in bone and its effect on the histomorphometry of trabecular bone was studied. Bone samples were taken from cadavers from a low-fluoride area (fluoride concentration under 0.3 ppm), an area with fluoridated drinking water (1.0-1.2 ppm) and a high-fluoride area (over 1.5 ppm). The fluoride content in trabecular bone was greatly increased in the high-fluoride area, and it was also higher in the fluoridated-water area than in the low-fluoride area. Histomorphometric bone changes were markedly increased when the fluoride content in water exceeded 1.5 ppm.
Article
Sural nerve biopsies from 13 patients with radiologically confirmed skeletal fluorosis were studied for myelinated fibre densities, frequency distribution of their diameters, and single teased nerve fibre preparations. It was observed that most of the biopsies showed a marked reduction in myelinated fibre densities with more than half of them involving the smaller fibres of less than 7 μm diameter. Teased fibre measurements of internodal lengths and internodal diameters point to myelinated fibre dropout being due to axonal degeneration with secondary demyelination. The selective loss of small fibres is unlikely to be due to an entrapment neuropathy alone, and possibility of primary toxic injury needs to be considered.
In: Chopra JS, Sawhney IMS eds
  • Dr Reddy
  • Sr Deme
  • B I Fluorosis
  • Churchill
  • Livingstone
Reddy DR, Deme SR, Fluorosis . In: Chopra JS, Sawhney IMS eds. Neurology in Tropics, B.I. Churchill Livingstone, New Delhi, India: 1999; 82–92
Studies in sural nerve biopsies in endemic skeletal fluorosis
  • B Sesikaran
  • S M Rao
  • D Krishnamurti
  • D R Reddy